What is the current annual cash & cash equivalents of LLY?

As of today, LLY annual cash & cash equivalents is $7.27B

What is 1-year change in LLY annual cash & cash equivalents?

LLY annual cash & cash equivalents is up +112.32% year-over-year

What is 3-year change in LLY annual cash & cash equivalents?

LLY annual cash & cash equivalents is up +228.60% over the past 3 years

How far is LLY annual cash & cash equivalents from its all-time high?

LLY annual cash & cash equivalents is currently -9.54% below its historical high of $8.03B set on December 31, 2017

How does LLY annual cash & cash equivalents rank versus sector peers?

LLY annual cash & cash equivalents is higher than 98.41% of companies in Healthcare sector

When is LLY next annual earnings release?

The next annual earnings release for LLY is on February 3, 2027

What is the current quarterly cash & cash equivalents of LLY?

As of today, LLY quarterly cash & cash equivalents is $4.89B

What is LLY quarterly cash & cash equivalents most recent change?

LLY quarterly cash & cash equivalents was down -45.42% on September 30, 2026

What is 1-year change in LLY quarterly cash & cash equivalents?

LLY quarterly cash & cash equivalents is down -50.72% year-over-year

How far is LLY quarterly cash & cash equivalents from its all-time high?

LLY quarterly cash & cash equivalents is currently -50.72% below its historical high of $9.91B set on September 30, 2025

How does LLY quarterly cash & cash equivalents rank versus sector peers?

LLY quarterly cash & cash equivalents is higher than 97.58% of companies in Healthcare sector

When is LLY next earnings release?

The next earnings release for LLY is on February 3, 2027

LLY Cash & Equivalents History & Chart Since 1984

Annual Cash & Cash Equivalents

$7.27B$3.84B+112.32%

December 31, 2025

Summary

Current Value: As of today, LLY annual cash & cash equivalents is $7.27B, up +112.32% on December 31, 2025
Historical Performance: LLY annual cash & cash equivalents is up +228.60% over the past 3 years, up +97.43% over the past 5 years
All-Time High Comparison: LLY annual cash & cash equivalents is currently -9.54% below its historical high of $8.03B set on December 31, 2017
3-Year Low Comparison: LLY annual cash & cash equivalents is +228.60% above its 3-year low of $2.21B reached on an earlier date
Sector Comparison: LLY annual cash & cash equivalents is higher than 98.41% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

LLY Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$7.27B	+112.3%	+228.6%	+97.4%	+8.0%
Quarterly Cash & Cash Equivalents	Sep 30, 26	$4.89B	-50.7%	+95.9%	+27.7%	-28.0%
Price	Nov 10, 26	$1,432.29	+44.9%	+139.6%	+445.4%	+3684.1%
Annual Current Assets	Dec 31, 25	$55.63B	+69.9%	+208.5%	+218.6%	+274.9%
Annual Total Liabilities	Dec 31, 25	$85.94B	+33.4%	+122.0%	+110.6%	+362.3%
Annual Working Capital	Dec 31, 25	$20.40B	+367.6%	+2176.1%	+309.6%	+163.6%
Annual Net Income	Dec 31, 25	$20.64B	+94.9%	+230.5%	+233.2%	+307.1%

Cash and Cash Equivalents Highs

LLY Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$7.27B	Dec 31, 25	at high
5Y	$7.27B	Dec 31, 25	at high
All	$8.03B	Dec 31, 17	-9.5%

Cash and Cash Equivalents Lows

LLY Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$2.21B	N/A	+228.6%
5Y	$2.21B	Dec 31, 22	+228.6%
All	$406.10M	Dec 31, 85	+1689.7%

Cash and Cash Equivalents History

Year	Value	Change
2025	$7.27B	+112.3%
2024	$3.42B	+16.9%
2023	$2.93B	+32.4%
2022	$2.21B	-43.4%
2021	$3.91B	+6.2%
2020	$3.68B	+51.0%
2019	$2.44B	-67.1%
2018	$7.41B	-7.8%
2017	$8.03B	+33.0%
2016	$6.04B	+35.6%
2015	$4.45B	-7.8%
2014	$4.83B	-10.6%
2013	$5.40B	-5.0%
2012	$5.68B	-17.6%
2011	$6.90B	+2.5%
2010	$6.73B	+49.6%
2009	$4.50B	-24.1%
2008	$5.93B	+22.7%
2007	$4.83B	+24.2%
2006	$3.89B	-22.8%
2005	$5.04B	-32.5%

Year	Value	Change
2004	$7.46B	+101.0%
2003	$3.71B	+1.6%
2002	$3.65B	-2.0%
2001	$3.73B	-19.2%
2000	$4.62B	+20.4%
1999	$3.84B	+140.2%
1998	$1.60B	-21.1%
1997	$2.02B	+112.0%
1996	$955.10M	-11.9%
1995	$1.08B	+45.2%
1994	$746.70M	-24.4%
1993	$987.10M	+35.5%
1992	$728.30M	-6.9%
1991	$782.40M	+20.0%
1989	$652.00M	-14.4%
1988	$761.50M	-26.1%
1987	$1.03B	+112.1%
1986	$486.00M	+19.7%
1985	$406.10M	-8.8%
1984	$445.30M	-

FAQ

What is the current annual cash & cash equivalents of LLY?: As of today, LLY annual cash & cash equivalents is $7.27B
What is 1-year change in LLY annual cash & cash equivalents?: LLY annual cash & cash equivalents is up +112.32% year-over-year
What is 3-year change in LLY annual cash & cash equivalents?: LLY annual cash & cash equivalents is up +228.60% over the past 3 years
How far is LLY annual cash & cash equivalents from its all-time high?: LLY annual cash & cash equivalents is currently -9.54% below its historical high of $8.03B set on December 31, 2017
How does LLY annual cash & cash equivalents rank versus sector peers?: LLY annual cash & cash equivalents is higher than 98.41% of companies in Healthcare sector
When is LLY next annual earnings release?: The next annual earnings release for LLY is on February 3, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$4.89B$4.07B-45.42%

September 30, 2026

Summary

Current Value: As of today, LLY quarterly cash & cash equivalents is $4.89B, down -45.42% on September 30, 2026
Historical Performance: LLY quarterly cash & cash equivalents is down -50.72% year-over-year, up +95.88% over the past 3 years
All-Time High Comparison: LLY quarterly cash & cash equivalents is currently -50.72% below its historical high of $9.91B set on September 30, 2025
3-Year Low Comparison: LLY quarterly cash & cash equivalents is +95.88% above its 3-year low of $2.49B reached on an earlier date
Sector Comparison: LLY quarterly cash & cash equivalents is higher than 97.58% of companies in Healthcare sector

Performance

LLY Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Sep 30, 26	$4.89B	-45.4%	-50.7%	+95.9%	+27.7%
Annual Cash & Cash Equivalents	Dec 31, 25	$7.27B	–	+112.3%	+228.6%	+97.4%
Price	Nov 10, 26	$1,432.29	+17.9%	+44.9%	+139.6%	+445.4%
Quarterly Current Assets	Sep 30, 26	$65.26B	+0.9%	+5.1%	+183.7%	+266.5%
Quarterly Total Liabilities	Sep 30, 26	$107.80B	-0.6%	+18.4%	+131.3%	+167.9%
Quarterly Working Capital	Sep 30, 26	$18.27B	+7.9%	-16.7%	+1710.8%	+342.7%
Quarterly Net Income	Sep 30, 26	$6.45B	-9.1%	+15.6%	+10000.0%	+481.1%

Quarterly Cash & Cash Equivalents Highs

LLY Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$9.91B	N/A	-50.7%
3Y	$9.91B	Sep 30, 25	-50.7%
5Y	$9.91B	Sep 30, 25	-50.7%
All	$9.91B	Sep 30, 25	-50.7%

Quarterly Cash & Cash Equivalents Lows

LLY Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$4.89B	Sep 30, 26	at low
3Y	$2.49B	N/A	+95.9%
5Y	$2.21B	Dec 31, 22	+120.9%
All	$230.40M	Jun 30, 91	+2020.2%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Sep 2026	$4.89B	-45.4%
Jun 2026	$8.95B	+69.4%
Mar 2026	$5.28B	-27.3%
Dec 2025	$7.27B	-26.7%
Sep 2025	$9.91B	+179.6%
Jun 2025	$3.55B	+10.1%
Mar 2025	$3.22B	-5.9%
Dec 2024	$3.42B	-2.7%
Sep 2024	$3.52B	+4.6%
Jun 2024	$3.36B	+30.1%
Mar 2024	$2.59B	-11.7%
Dec 2023	$2.93B	+17.4%
Sep 2023	$2.49B	-11.8%
Jun 2023	$2.83B	-22.9%
Mar 2023	$3.67B	+65.9%
Dec 2022	$2.21B	-19.3%
Sep 2022	$2.74B	+0.2%
Jun 2022	$2.74B	+6.6%
Mar 2022	$2.57B	-34.3%
Dec 2021	$3.91B	+2.2%
Sep 2021	$3.83B	+16.9%
Jun 2021	$3.27B	+7.2%
Mar 2021	$3.05B	-17.1%
Dec 2020	$3.68B	+1.4%
Sep 2020	$3.63B	+52.0%
Jun 2020	$2.39B	+34.3%
Mar 2020	$1.78B	-27.1%
Dec 2019	$2.44B	+47.5%
Sep 2019	$1.65B	-30.2%
Jun 2019	$2.37B	+10.8%
Mar 2019	$2.14B	-71.2%
Dec 2018	$7.41B	-18.0%
Sep 2018	$9.04B	+30.8%
Jun 2018	$6.91B	+44.3%
Mar 2018	$4.79B	-40.4%
Dec 2017	$8.03B	+15.7%
Sep 2017	$6.94B	+27.8%
Jun 2017	$5.43B	+55.0%
Mar 2017	$3.51B	-41.9%
Dec 2016	$6.04B	+42.9%
Sep 2016	$4.23B	+7.4%
Jun 2016	$3.93B	+31.4%
Mar 2016	$3.00B	-32.7%
Dec 2015	$4.45B	+3.1%
Sep 2015	$4.32B	+2.1%
Jun 2015	$4.23B	+2.2%
Mar 2015	$4.14B	-14.2%
Dec 2014	$4.83B	+0.4%
Sep 2014	$4.81B	-6.2%
Jun 2014	$5.13B	-1.6%
Mar 2014	$5.21B	-3.4%
Dec 2013	$5.40B	+0.3%
Sep 2013	$5.38B	+14.2%
Jun 2013	$4.71B	-0.5%
Mar 2013	$4.73B	-16.7%
Dec 2012	$5.68B	-17.6%
Sep 2012	$6.90B	+31.1%
Jun 2012	$5.26B	+6.8%
Mar 2012	$4.92B	-28.6%
Dec 2011	$6.90B	+1.7%
Sep 2011	$6.78B	+7.2%
Jun 2011	$6.33B	-5.7%
Mar 2011	$6.71B	-0.2%
Dec 2010	$6.73B	+9.6%
Sep 2010	$6.14B	+18.2%
Jun 2010	$5.20B	+9.2%
Mar 2010	$4.76B	+5.8%
Dec 2009	$4.50B	+14.5%
Sep 2009	$3.93B	+12.6%

Month	Value	Change
Jun 2009	$3.49B	-0.5%
Mar 2009	$3.51B	-40.8%
Dec 2008	$5.93B	-3.1%
Sep 2008	$6.12B	+18.4%
Jun 2008	$5.17B	-4.9%
Mar 2008	$5.43B	+12.5%
Dec 2007	$4.83B	+35.5%
Sep 2007	$3.57B	+18.7%
Jun 2007	$3.00B	-10.7%
Mar 2007	$3.36B	-13.5%
Dec 2006	$3.89B	+7.5%
Sep 2006	$3.62B	-21.2%
Jun 2006	$4.59B	+1.9%
Mar 2006	$4.50B	-10.6%
Dec 2005	$5.04B	-19.2%
Sep 2005	$6.23B	+15.4%
Jun 2005	$5.40B	-3.9%
Mar 2005	$5.62B	+50.6%
Dec 2001	$3.73B	-19.2%
Dec 2000	$4.62B	+20.4%
Dec 1999	$3.84B	+14.2%
Sep 1999	$3.36B	+60.2%
Jun 1999	$2.10B	-14.4%
Mar 1999	$2.45B	+53.4%
Dec 1998	$1.60B	-1.2%
Sep 1998	$1.62B	+16.9%
Jun 1998	$1.38B	+4.1%
Mar 1998	$1.33B	-31.8%
Dec 1997	$1.95B	+29.5%
Sep 1997	$1.50B	-18.8%
Jun 1997	$1.85B	+77.8%
Mar 1997	$1.04B	+28.1%
Dec 1996	$813.70M	+10.2%
Sep 1996	$738.10M	-34.4%
Jun 1996	$1.13B	+25.2%
Mar 1996	$898.40M	-10.1%
Dec 1995	$999.50M	+2.4%
Sep 1995	$976.20M	-1.4%
Jun 1995	$989.70M	+1.1%
Mar 1995	$978.80M	+82.3%
Dec 1994	$536.90M	-46.3%
Sep 1994	$999.60M	+41.4%
Jun 1994	$706.80M	+16.8%
Mar 1994	$604.90M	+12.1%
Dec 1993	$539.60M	-15.2%
Sep 1993	$636.10M	+42.1%
Jun 1993	$447.70M	-24.7%
Mar 1993	$594.60M	+37.5%
Dec 1992	$432.40M	+21.7%
Sep 1992	$355.20M	-16.5%
Jun 1992	$425.40M	+21.1%
Mar 1992	$351.30M	-26.7%
Dec 1991	$479.20M	+63.3%
Sep 1991	$293.50M	+27.4%
Jun 1991	$230.40M	-23.9%
Mar 1991	$302.80M	-13.5%
Dec 1990	$350.20M	-29.1%
Sep 1990	$494.00M	+7.6%
Jun 1990	$459.10M	+9.5%
Mar 1990	$419.30M	+29.8%
Dec 1989	$323.00M	-45.0%
Sep 1989	$587.40M	+2.6%
Jun 1989	$572.40M	-24.8%
Dec 1988	$761.50M	-26.1%
Dec 1987	$1.03B	+112.1%
Dec 1986	$486.00M	+19.7%
Dec 1985	$406.10M	-8.8%
Dec 1984	$445.30M	-

FAQ

What is the current quarterly cash & cash equivalents of LLY?: As of today, LLY quarterly cash & cash equivalents is $4.89B
What is LLY quarterly cash & cash equivalents most recent change?: LLY quarterly cash & cash equivalents was down -45.42% on September 30, 2026
What is 1-year change in LLY quarterly cash & cash equivalents?: LLY quarterly cash & cash equivalents is down -50.72% year-over-year
How far is LLY quarterly cash & cash equivalents from its all-time high?: LLY quarterly cash & cash equivalents is currently -50.72% below its historical high of $9.91B set on September 30, 2025
How does LLY quarterly cash & cash equivalents rank versus sector peers?: LLY quarterly cash & cash equivalents is higher than 97.58% of companies in Healthcare sector
When is LLY next earnings release?: The next earnings release for LLY is on February 3, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

LLY Official Website www.lilly.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/59478/000005947826000013/0000059478-26-000013-index.htm
LLY Profile on Yahoo Finance finance.yahoo.com/quote/LLY
LLY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lly